The sale is small and routine; no material impact on the stock is expected. Monitor for any subsequent Form 4 filings to confirm execution, but no further action warranted.
LH drugs
LH drug pipeline →Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Amy B. Summy, an officer of Labcorp, filed a Form 144 notice of intent to sell 365 shares of common stock, with an approximate market value of $135,992. The sale is scheduled for November 16, 2026, and the shares were acquired through restricted stock vesting on March 30, 2023. This is a routine, small-scale sale by an officer, likely for personal tax or estate planning purposes, and does not signal a change in company outlook.
Key Facts
- Insider: Amy B. Summy, an officer of Labcorp Holdings Inc.
- Securities to be sold: 365 shares of common stock
- Approximate market value: $135,991.70
- Sale date: November 16, 2026
- Shares acquired on March 30, 2023 via restricted stock vesting
- Broker: Fidelity Brokerage Services LLC
Financial Impact
Sale of 365 shares valued at approximately $135,992, representing a negligible fraction of the company's market cap.
Risk Factors
- Insider sale could be perceived negatively if it precedes adverse news, but the small size mitigates this risk.
- The filing is an intent to sell; the actual sale may not occur.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-008069 |
| Document: 0001959173-26-008069-index.html | 0001959173-26-008069 |
| Document: 0001959173-26-008069.txt | 0001959173-26-008069 |
Track record
31 reports on LH
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.60% at T+60 after the Apr 30, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 17, 2026today Press Release Neutral 3/10 Entry price pending
- Nov 16, 20261d ago 144 Neutral 2/10 Viewing Entry $372.46 Now $368.24 −1.13% settles Nov 24
- Nov 12, 20265d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $368.24 −1.10% settles Nov 19
- Nov 10, 20267d ago 144 Neutral 2/10 Entry $372.23 Now $368.24 −1.07% settles Nov 18
- Nov 5, 202612d ago Insider Cluster Neutral 2/10 Entry $363.30 to $372.32 Now $368.24 +1.36% ▲ +2.48% −0.81% vs SPY
- Nov 4, 202613d ago 144 Neutral 2/10 Entry $367.79 to $372.23 Now $368.24 +0.12% ▲ +1.21% +2.12% vs SPY
- Nov 4, 202613d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $368.24 +0.12% ▲ +1.21% +2.12% vs SPY
- Nov 3, 202614d ago 144 Neutral 2/10 Entry $353.92 to $370.88 Now $368.24 +4.05% ▲ +4.79% +5.38% vs SPY
- Oct 30, 202618d ago 144 Neutral 2/10 Entry $361.39 to $366.57 Now $368.24 +1.90% ▲ +1.43% +4.14% vs SPY
- Oct 28, 202620d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $368.24 +2.22% ▲ +2.09% +2.81% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers